To analyze whether electrocardiographic alterations (ECGA) in patients with antibodies to Trypanosoma cruzi showed a patttern of familial aggregation, a sample of 379 young adults (166 men and 213 women) distributed in sibships, were assessed for the presence of anti-T.cruzi antibodies, and subjected to a complete clinical examination and a standard resting electrocardiogram (ECG). Positive T. cruzi serology was detected in 165 individuals, 48 of them showing an abnormal ECG (overall prevalence 29 por cento). One hundred and eleven seropositive individuals were distributed in 45 sibships, each of them constituted by more than one seropositive sib, with ECGA being present in 34 out of these patients. Seropositive subjects with ECGA were dete...
BackgroundThe significance of detection of Trypanosoma cruzi DNA in blood of antibody-positive patie...
textabstractBackground: Chagas disease (CD) is a major public health concern in Latin America and a ...
<div><p>Chagas disease (CD) affects over six million people and is a leading cause of cardiomyopathy...
Texto completo. Acesso restrito. p. 287–294The relationship of infection with TryPanosoma cruzi to E...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing nu...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing nu...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing n...
Abstract. As part of a major epidemiologic study on Chagas ’ disease, we compared the prevalence of ...
This study compared the serological and electrocardiographic evolution among patients with chronic T...
Chagas disease caused by the protozoan Trypanosoma cruzi is the leading cause of heart disease in La...
BackgroundBlood donor screening leads to large numbers of new diagnoses of Trypanosoma cruzi infecti...
BackgroundAlthough infection with Trypanosoma cruzi is thought to be lifelong, less than half of tho...
BackgroundVery few studies have measured disease penetrance and prognostic factors of Chagas cardiom...
© 2015, The Author(s).There are currently no biomarkers to assess which patients with chronic indete...
BACKGROUND:Chagas disease (CD) is a major public health concern in Latin America and a potentially s...
BackgroundThe significance of detection of Trypanosoma cruzi DNA in blood of antibody-positive patie...
textabstractBackground: Chagas disease (CD) is a major public health concern in Latin America and a ...
<div><p>Chagas disease (CD) affects over six million people and is a leading cause of cardiomyopathy...
Texto completo. Acesso restrito. p. 287–294The relationship of infection with TryPanosoma cruzi to E...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing nu...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing nu...
In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing n...
Abstract. As part of a major epidemiologic study on Chagas ’ disease, we compared the prevalence of ...
This study compared the serological and electrocardiographic evolution among patients with chronic T...
Chagas disease caused by the protozoan Trypanosoma cruzi is the leading cause of heart disease in La...
BackgroundBlood donor screening leads to large numbers of new diagnoses of Trypanosoma cruzi infecti...
BackgroundAlthough infection with Trypanosoma cruzi is thought to be lifelong, less than half of tho...
BackgroundVery few studies have measured disease penetrance and prognostic factors of Chagas cardiom...
© 2015, The Author(s).There are currently no biomarkers to assess which patients with chronic indete...
BACKGROUND:Chagas disease (CD) is a major public health concern in Latin America and a potentially s...
BackgroundThe significance of detection of Trypanosoma cruzi DNA in blood of antibody-positive patie...
textabstractBackground: Chagas disease (CD) is a major public health concern in Latin America and a ...
<div><p>Chagas disease (CD) affects over six million people and is a leading cause of cardiomyopathy...